{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:35:02Z","timestamp":1792143302664,"version":"4.4.0"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:p>Left ventricular assist devices (LVADs), which were introduced as a bridge to heart transplantation, are now an established alternative to heart transplantation (HT) for patients with advanced heart failure. These devices have undergone significant technological advancements over the years, and contemporary LVADs prolong life substantially in patients dependent on inotropic therapy or in those with severe ambulatory advanced heart failure with a median survival that exceeds 5 y, and most patients benefit from a doubling in functional capacity, even among those intended as destination therapy because of ineligibility for transplantation. Other intended goals for LVAD implantation consist of (1) bridge to remission or recovery and (2) bridge to transplant or candidacy for transplant. In the former situation, few selected patients underwent LVAD implantation, facilitating myocardial remission to recovery that allowed explantation. Among those bridged to transplantation, survival in the intended goal was excellent, with 80% success at 5 y (with a 50% rate of transplantation). In this review, we provide a brief historical background on the evolution of LVADs and discuss outcomes with contemporary pumps, immunological and infection-related impact of such devices, impact of bridging in HT, and use of devices for facilitating myocardial recovery and remission. Furthermore, we discuss implications of HT allocation policies, with a specific focus within the United States, and outline future perspectives and novel device in development.<\/jats:p>","DOI":"10.1097\/tp.0000000000004834","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T00:01:53Z","timestamp":1698105713000},"page":"1333-1341","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":29,"title":["Contemporary Left Ventricular Assist Device Therapy as a Bridge or Alternative to Transplantation"],"prefix":"10.1097","volume":"108","author":[{"given":"Jacinthe","family":"Boulet","sequence":"first","affiliation":[{"name":"Center for Advanced Heart Disease, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro R.B.","family":"Wanderley","sequence":"additional","affiliation":[{"name":"Center for Advanced Heart Disease, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep R.","family":"Mehra","sequence":"additional","affiliation":[{"name":"Center for Advanced Heart Disease, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,24]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9149(71)90076-2","article-title":"Left ventricular bypass pump for cardiac assistance. Clinical experience.","volume":"27","author":"DeBakey","year":"1971","journal-title":"Am J Cardiol"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1900486","article-title":"A fully magnetically levitated left ventricular assist device\u2014final report.","volume":"380","author":"Mehra","year":"2019","journal-title":"N Engl J Med"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jamacardio.2020.0631","article-title":"Strategies of wait-listing for heart transplant vs durable mechanical circulatory support alone for patients with advanced heart failure.","volume":"5","author":"Lala","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jamacardio.2019.5323","article-title":"Association of clinical outcomes with left ventricular assist device use by bridge to transplant or destination therapy intent: the multicenter study of MagLev technology in patients undergoing mechanical circulatory support therapy with HeartMate 3 (MOMENTUM 3) randomized clinical trial.","volume":"5","author":"Goldstein","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.athoracsur.2020.12.038","article-title":"The Society of Thoracic Surgeons Intermacs 2020 annual report.","volume":"111","author":"Molina","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/ejhf.2211","article-title":"Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants.","volume":"23","author":"Mehra","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.2022.16197","article-title":"Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial.","volume":"328","author":"Mehra","year":"2022","journal-title":"JAMA"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jchf.2022.03.007","article-title":"Hospitalization patterns and impact of a magnetically-levitated left ventricular assist device in the MOMENTUM 3 trial.","volume":"10","author":"Vidula","year":"2022","journal-title":"JACC Heart Fail"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.cardfail.2022.09.007","article-title":"Hemodynamic aberrancies in left ventricular assist device-associated heart failure syndromes.","volume":"28","author":"Boulet","year":"2022","journal-title":"J Card Fail"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jchf.2022.08.002","article-title":"Prediction of survival after implantation of a fully magnetically levitated left ventricular assist device.","volume":"10","author":"Mehra","year":"2022","journal-title":"JACC Heart Fail"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/24748706.2021.1954275","article-title":"Left ventricular reverse remodeling in heart failure: remission to recovery.","volume":"5","author":"Boulet","year":"2021","journal-title":"Structural Heart"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.athoracsur.2019.12.005","article-title":"The Society of Thoracic Surgeons Intermacs 2019 annual report: the changing landscape of devices and indications.","volume":"109","author":"Teuteberg","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)32484-X","article-title":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial.","volume":"393","author":"Halliday","year":"2019","journal-title":"Lancet"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1056\/NEJMoa053063","article-title":"Left ventricular assist device and drug therapy for the reversal of heart failure.","volume":"355","author":"Birks","year":"2006","journal-title":"N Engl J Med"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/CIRCULATIONAHA.120.046415","article-title":"Prospective multicenter study of myocardial recovery using left ventricular assist devices (RESTAGE-HF [Remission from Stage D Heart Failure]): medium-term and primary end point results.","volume":"142","author":"Birks","year":"2020","journal-title":"Circulation"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/ehf2.12629","article-title":"Outcomes of patients after successful left ventricular assist device explantation: a EUROMACS study.","volume":"7","author":"Antonides","year":"2020","journal-title":"ESC Heart Fail"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.healun.2022.05.015","article-title":"Clinical myocardial recovery in advanced heart failure with long term left ventricular assist device support.","volume":"41","author":"Kanwar","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/jama.2019.2341","article-title":"Intramyocardial injection of mesenchymal precursor cells and successful temporary weaning from left ventricular assist device support in patients with advanced heart failure: a randomized clinical trial.","volume":"321","author":"Yau","year":"2019","journal-title":"JAMA"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cardfail.2019.01.002","article-title":"Increases in serum autoantibodies after left ventricular assist device implantation.","volume":"25","author":"Grosman-Rimon","year":"2019","journal-title":"J Card Fail"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.healun.2021.11.010","article-title":"Post-transplantation outcomes of sensitized patients receiving durable mechanical circulatory support.","volume":"41","author":"Youn","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/jocs.14066","article-title":"Outcomes after heart transplantation in sensitized patients bridged with ventricular assist devices.","volume":"34","author":"Fraser","year":"2019","journal-title":"J Card Surg"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"101567","DOI":"10.1016\/j.trim.2022.101567","article-title":"De novo human leukocyte antigen allosensitization patterns in patients bridged to heart transplantation using left ventricular assist devices.","volume":"72","author":"Chau","year":"2022","journal-title":"Transpl Immunol"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MAT.0000000000001119","article-title":"Impact of induction immunosuppression on post-transplant outcomes of patients bridged with contemporary left ventricular assist devices.","volume":"66","author":"Truby","year":"2020","journal-title":"ASAIO J"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.athoracsur.2008.01.050","article-title":"Cellular immunity impaired among patients on left ventricular assist device for 6 months.","volume":"85","author":"Kimball","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"186","DOI":"10.21037\/acs-2021-cfmcs-35","article-title":"Contemporary outcomes of continuous-flow left ventricular assist devices\u2014a systematic review.","volume":"10","author":"McNamara","year":"2021","journal-title":"Ann Cardiothorac Surg"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.healun.2020.03.002","article-title":"Left ventricular assist systems and infection-related outcomes: a comprehensive analysis of the MOMENTUM 3 trial.","volume":"39","author":"Patel","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.amjcard.2021.08.044","article-title":"Relation of left ventricular assist device infections with cardiac transplant outcomes.","volume":"160","author":"Parikh","year":"2021","journal-title":"Am J Cardiol"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/jocs.16073","article-title":"Association between continuous-flow left ventricular assist device infections requiring long-term antibiotic use and post-heart transplant morbidity and mortality.","volume":"37","author":"Lambadaris","year":"2022","journal-title":"J Card Surg"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"e13692","DOI":"10.1111\/ctr.13692","article-title":"Outcomes of patients with infection related to a ventricular assist device after heart transplantation.","volume":"33","author":"Moayedi","year":"2019","journal-title":"Clin Transplant"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.healun.2019.02.006","article-title":"Stroke and death risk in ventricular assist device patients varies by ISHLT infection category: an INTERMACS analysis.","volume":"38","author":"Shah","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.healun.2019.05.010","article-title":"The new tiered allocation system for heart transplantation in the United States\u2014a Faustian bargain.","volume":"38","author":"Bernhardt","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2019.11.002","article-title":"An early investigation of outcomes with the new 2018 donor heart allocation system in the United States.","volume":"39","author":"Cogswell","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jchf.2021.01.010","article-title":"Changes in use of left ventricular assist devices as bridge to transplantation with new heart allocation policy.","volume":"9","author":"Mullan","year":"2021","journal-title":"JACC Heart Fail"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2022.01.017","article-title":"Trends and outcomes of left ventricular assist device therapy: JACC Focus Seminar.","volume":"79","author":"Varshney","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/ajt.15816","article-title":"New French heart allocation system: comparison with Eurotransplant and US allocation systems.","volume":"20","author":"Dorent","year":"2020","journal-title":"Am J Transplant"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jchf.2023.01.009","article-title":"Impact of the 2018 UNOS Heart Transplant Policy changes on patient outcomes.","volume":"11","author":"Maitra","year":"2023","journal-title":"JACC Heart Fail"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.cardfail.2021.06.003","article-title":"Left ventricular assist devices at the crossroad of innovation in advanced heart failure.","volume":"27","author":"Mehra","year":"2021","journal-title":"J Card Fail"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ejhf.1340","article-title":"Evolving disruption in left ventricular assist systems: forgiving but not yet forgettable.","volume":"21","author":"Mehra","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.healun.2019.01.1316","article-title":"First human use of a wireless coplanar energy transfer coupled with a continuous-flow left ventricular assist device.","volume":"38","author":"Pya","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.healun.2017.03.014","article-title":"A new \u201ctwist\u201d on right heart failure with left ventricular assist systems.","volume":"36","author":"Houston","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa040186","article-title":"Cardiac replacement with a total artificial heart as a bridge to transplantation.","volume":"351","author":"Copeland","year":"2004","journal-title":"N Engl J Med"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/aor.14077","article-title":"Anatomical human fitting of the BiVACOR total artificial heart.","volume":"46","author":"Emmanuel","year":"2022","journal-title":"Artif Organs"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/MAT.0000000000001485","article-title":"First clinical experience with the pressure sensor-based autoregulation of blood flow in an artificial heart.","volume":"67","author":"Netuka","year":"2021","journal-title":"ASAIO J"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.jacc.2019.09.004","article-title":"Advanced heart failure therapies for adults with congenital heart disease: JACC state-of-the-art review.","volume":"74","author":"Givertz","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jacbts.2022.05.003","article-title":"Cardiac xenotransplantation: challenges, evolution, and advances.","volume":"7","author":"Boulet","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/bioengineering6010018","article-title":"Cardiac assist devices: early concepts, current technologies, and future innovations.","volume":"6","author":"Han","year":"2019","journal-title":"Bioengineering (Basel)"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijcard.2018.09.085","article-title":"Percutaneous haemodynamic and renal support in patients presenting with decompensated heart failure: a multi-centre efficacy study using the Reitan Catheter Pump (RCP).","volume":"275","author":"Keeble","year":"2019","journal-title":"Int J Cardiol"},{"key":"R50-20250604","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2023.06.015","article-title":"Expanding use of the HeartMate 3 ventricular assist device in pediatric and adult patients within the Advanced Cardiac Therapies Improving Outcomes Network (ACTION).","author":"O\u2019Connor","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.healun.2021.11.014","article-title":"A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: a United Kingdom perspective.","volume":"41","author":"Lim","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1161\/CIRCULATIONAHA.118.035722","article-title":"Healthcare resource use and cost implications in the MOMENTUM 3 long-term outcome study.","volume":"138","author":"Mehra","year":"2018","journal-title":"Circulation"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/ejhf.2570","article-title":"Global challenges in left ventricular assist device therapy: a tale across two continents.","volume":"24","author":"Nayak","year":"2022","journal-title":"Eur J Heart Fail"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T14:05:34Z","timestamp":1749045934000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,24]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004834","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,24]]}}}